Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Disease modification and other trials in systemic sclerosis have come a long way, but have to go further.

Pope JE, Khanna D, Johnson SR, Clements P.

Arthritis Care Res (Hoboken). 2012 Jul;64(7):955-9. doi: 10.1002/acr.21673. No abstract available.

2.

Systemic sclerosis disease modification clinical trials design: quo vadis?

Mendoza FA, Keyes-Elstein LL, Jimenez SA.

Arthritis Care Res (Hoboken). 2012 Jul;64(7):945-54. doi: 10.1002/acr.21667. No abstract available.

3.

D-penicillamine is not an effective treatment in systemic sclerosis.

Furst DE, Clements PJ.

Scand J Rheumatol. 2001;30(4):189-91. Review.

PMID:
11578010
4.

D-penicillamine in systemic sclerosis? Yes!

Medsger TA Jr, Lucas M, Wildy KS, Baker C.

Scand J Rheumatol. 2001;30(4):192-4. Review.

PMID:
11578011
5.

Treatment of scleroderma.

Gelber AC, Wigley FM.

Curr Opin Rheumatol. 1995 Nov;7(6):551-9. Review.

PMID:
8579978
6.

Systemic sclerosis: hypothesis-driven treatment strategies.

Charles C, Clements P, Furst DE.

Lancet. 2006 May 20;367(9523):1683-91. Review.

PMID:
16714190
7.

Clinical trials for the treatment of systemic sclerosis/scleroderma.

Varga J, Ponor I.

Curr Rheumatol Rep. 1999 Oct;1(1):13-4. Review. No abstract available.

PMID:
11123008
8.

Disease-modifying drugs for systemic sclerosis: why have we not found them yet?

Derk CT.

Expert Rev Clin Immunol. 2011 Jul;7(4):399-401. doi: 10.1586/eci.11.29. No abstract available.

PMID:
21790280
9.

Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis.

White B, Bauer EA, Goldsmith LA, Hochberg MC, Katz LM, Korn JH, Lachenbruch PA, LeRoy EC, Mitrane MP, Paulus HE, et al.

Arthritis Rheum. 1995 Mar;38(3):351-60.

PMID:
7880189
10.

[Evidence-based therapy of systemic sclerosis].

Genth E.

Z Rheumatol. 2001 Dec;60(6):464-8. Review. German.

PMID:
11826742
11.

Discordant response to rituximab in a systemic sclerosis patient with associated myositis.

Fabri M, Hunzelmann N, Krieg T, Rubbert A.

J Am Acad Dermatol. 2008 May;58(5 Suppl 1):S127-8. doi: 10.1016/j.jaad.2007.06.010. No abstract available.

PMID:
18489049
12.

Successful treatment with leflunomide of arthritis in systemic sclerosis patients.

Sebastiani M, Giuggioli D, Vesprini E, Caruso A, Ferri C.

Rheumatology (Oxford). 2006 Sep;45(9):1175-6. Epub 2006 Jul 4. No abstract available.

PMID:
16820378
13.

Clinical trials for pediatric scleroderma.

Rosenkranz ME, Lehman TJ.

Curr Rheumatol Rep. 2002 Dec;4(6):449-51.

PMID:
12427357
14.

Combination therapies for systemic sclerosis.

Denton CP, Black CM.

Springer Semin Immunopathol. 2001;23(1-2):109-29. Review. No abstract available.

PMID:
11455851
15.

Cyclosporine in the treatment of an unusual case of juvenile systemic sclerosis.

al-Mayouf SM, Silverman ED, Feldman BM, Thorner P, Laxer RM.

J Rheumatol. 1998 Apr;25(4):791-3.

PMID:
9558187
16.

The role of DMARDs in systemic sclerosis therapy.

Blank N, Max R, Lorenz HM.

Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii42-4. Review. Erratum in: Rheumatology (Oxford). 2008 Feb;47(2):234-5.

PMID:
16987834
17.

Innovative therapies for systemic sclerosis.

Ong VH, Denton CP.

Curr Opin Rheumatol. 2010 May;22(3):264-72. doi: 10.1097/BOR.0b013e328337c3d6. Review.

PMID:
20190640
18.

Effect of D-penicillamine on pulmonary fibrosis in patients with systemic sclerosis.

Jinnin M, Ihn H, Asano Y, Yamane K, Yazawa N, Tamaki K.

Ann Rheum Dis. 2003 Oct;62(10):1019-20. No abstract available.

19.

Cyclophosphamide therapy for scleroderma.

Akesson A.

Curr Opin Rheumatol. 1998 Nov;10(6):579-83.

PMID:
9812219
20.

Abatacept induces clinical improvement in patients with severe systemic sclerosis.

de Paoli FV, Nielsen BD, Rasmussen F, Deleuran B, Søndergaard K.

Scand J Rheumatol. 2014;43(4):342-5. doi: 10.3109/03009742.2013.812238. No abstract available.

PMID:
25088011

Supplemental Content

Support Center